comparison of potassium hydroxide and podophyllotoxin in the treatment of molluscum contagiosum
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Molluscum contagiosum
- Registration Number
- CTRI/2018/08/015198
- Lead Sponsor
- Dr Niharika Ranjan Lal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
patients of all ages and both sexes who are diagnosed with a MC infection (clinical diagnosis).
who have provided written informed consent for participation.
Exclusion Criteria
Immunocompromised patient (congenital or acquired).
Patient has received other topical treatment within the last month.
Pregnant and lactating women.
Patient who, in the view of the attending physician, will not comply with treatment and/or scheduled visits.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy will be assessed in each of the areas detected in the previous visit. If there are new areas affected, they will be evaluated at the next visit. The primary outcome will be calculated for each of the affected areas, as an indicator variable: (There is a lesion in the area/No lesion in the area) at 6th week from baseline. Each patient will be considered cured if they have no lesions in any of the treated areas.Timepoint: outcome will be assessed at 2nd, 4th and 6th weeks.
- Secondary Outcome Measures
Name Time Method Secondary efficacy variables (secondary endpoints) will be calculated for each location as follows: <br/ ><br>Number of lesions. <br/ ><br>Extent of area affected. <br/ ><br>Mean size of lesions <br/ ><br>Timepoint: 6 wwek